Armstrong Clinical provides clients only seasoned, experienced specialists in their field within clinical development

Whether it be biostatistics, clinical study design, regulatory strategy or clinical development strategy, you are receiving services from the best experts in pharmaceutical development.

Bradley Joblin (Clinical Project Management, Founder)

Bradley started his career as a commercialization consultant for the Australian Biotech industry, providing competitive intelligence and out licencing opportunity analysis to biotech companies. Bradley has since held Senior Manager and Director positions in Clinical Development and Project Management at the headquarters of global pharmaceutical companies, Roche Pharmaceuticals and AstraZeneca, as well as a contractor to design and manage early clinical development for smaller European biotechnology companies. Bradley has expertise is in bringing innovation into clinical study design to increase development efficiencies and save costs as well as understanding when and how to maximise cross-functional input and accurately forecast clinical development budgets and timelines.


Piet Bruijnzeel MD (Clinical Development)

Piet's 35 years clinical development and medical experience working as Director and Department Head of European medical research institutes (e.g. Swiss Institute of Asthma and Allergy Research), Medical Science Director at the headquarters of global pharmaceutical companies Merck and AstraZeneca has provided him a wealth of knowledge within clinical practice and particularly early therapeutic development. Piet has published close to 100 peer reviewed journals, is highly specialised in the respiratoy and immunology fields who's knowledge is a valuable asset to any clinical development program.


Patrick Johnson (Statistics)

Patrick has held senior positions in biometrics within the pharma industry including Head of Biometrics at Vifor Pharma and Associate Director of Pharamcometrics at Pfizer. Patrick is now the Director of his own statistical consisting company, JPharma Solutions, providing the range of statistical support for clinical development. Patrick specialises in PK modelling, adaptive design and all aspects of statistical input and oversight of PhI-IV clinical studies.


Jennifer Svec (Regulatory Affairs)

Should you wish to have your clinical studies conducted within Australia, Jennifer has worked in the Australian clinical research industry in regulatory affairs since 1998. Jennifer now is the director of her own company, The Reg Group Pty. Ltd. and provides expert regulatory services to the Australian industry.

Should you require regulatory personal with FDA, EMA or individual European country authority experience, Armstrong Clinical has contractors, located in, and with specialized regulatory expertise specific for each region.




2016 Armstrong Clinical Pty. Ltd.